Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
mBio ; 15(1): e0183223, 2024 Jan 16.
Article in English | MEDLINE | ID: mdl-38059639

ABSTRACT

IMPORTANCE: Our study leverages gene editing techniques in Plasmodium falciparum asexual blood stage parasites to profile novel mutations in mutant PfCRT, an important mediator of piperaquine resistance, which developed in Southeast Asian field isolates or in parasites cultured for long periods of time. We provide evidence that increased parasite fitness of these lines is the primary driver for the emergence of these PfCRT variants. These mutations differentially impact parasite susceptibility to piperaquine and chloroquine, highlighting the multifaceted effects of single point mutations in this transporter. Molecular features of drug resistance and parasite physiology were examined in depth using proteoliposome-based drug uptake studies and peptidomics, respectively. Energy minimization calculations, showing how these novel mutations might impact the PfCRT structure, suggested a small but significant effect on drug interactions. This study reveals the subtle interplay between antimalarial resistance, parasite fitness, PfCRT structure, and intracellular peptide availability in PfCRT-mediated parasite responses to changing drug selective pressures.


Subject(s)
Antimalarials , Malaria, Falciparum , Parasites , Piperazines , Quinolines , Animals , Plasmodium falciparum , Quinolines/pharmacology , Quinolines/chemistry , Chloroquine/pharmacology , Antimalarials/pharmacology , Drug Resistance/genetics , Mutation , Protozoan Proteins/genetics , Protozoan Proteins/chemistry , Malaria, Falciparum/parasitology
2.
PLOS Glob Public Health ; 2(6): e0000462, 2022.
Article in English | MEDLINE | ID: mdl-36962405

ABSTRACT

Despite worldwide efforts and much progress toward malaria control, declines in malaria morbidity and mortality have hit a plateau. While many nations achieved significant malaria suppression or even elimination, success has been uneven, and other nations have made little headway-or even lost ground in this battle. These alarming trends threaten to derail the attainment of global targets for malaria control. Among the challenges impeding success in malaria reduction, many strategies center malaria as a set of technical problems in commodity development and delivery. Yet, this narrow perspective overlooks the importance of strong health systems and robust healthcare delivery. This paper argues that strategies that move the needle on health services and behaviors offer a significant opportunity to achieve malaria control through a comprehensive approach that integrates malaria with broader health services efforts. Indeed, malaria may serve as the thread that weaves integrated service delivery into a path forward for universal health coverage. Using key themes identified by the "Rethinking Malaria in the Context of COVID-19" effort through engagement with key stakeholders, we provide recommendations for pursuing integrated service delivery that can advance malaria control via strengthening health systems, increasing visibility and use of high-quality data at all levels, centering issues of equity, promoting research and innovation for new tools, expanding knowledge on effective implementation strategies for interventions, making the case for investing in malaria among stakeholders, and engaging impacted communities and nations.

3.
Front Cell Infect Microbiol ; 11: 691121, 2021.
Article in English | MEDLINE | ID: mdl-34178727

ABSTRACT

Parasites of the phylum Apicomplexa impact humans in nearly all parts of the world, causing diseases including to toxoplasmosis, cryptosporidiosis, babesiosis, and malaria. Apicomplexan parasites have complex life cycles comprised of one or more stages characterized by rapid replication and biomass amplification, which enables accelerated evolutionary adaptation to environmental changes, including to drug pressure. The emergence of drug resistant pathogens is a major looming and/or active threat for current frontline chemotherapies, especially for widely used antimalarial drugs. In fact, resistant parasites have been reported against all modern antimalarial drugs within 15 years of clinical introduction, including the current frontline artemisinin-based combination therapies. Chemotherapeutics are a major tool in the public health arsenal for combatting the onset and spread of apicomplexan diseases. All currently approved antimalarial drugs have been discovered either through chemical modification of natural products or through large-scale screening of chemical libraries for parasite death phenotypes, and so far, none have been developed through a gene-to-drug pipeline. However, the limited duration of efficacy of these drugs in the field underscores the need for new and innovative approaches to discover drugs that can counter rapid resistance evolution. This review details both historical and current antimalarial drug discovery approaches. We also highlight new strategies that may be employed to discover resistance-resistant drug targets and chemotherapies in order to circumvent the rapid evolution of resistance in apicomplexan parasites.


Subject(s)
Antimalarials , Malaria , Parasites , Animals , Antimalarials/pharmacology , Drug Discovery , Drug Resistance , Humans , Malaria/drug therapy , Plasmodium falciparum
4.
Nat Commun ; 12(1): 1629, 2021 03 12.
Article in English | MEDLINE | ID: mdl-33712609

ABSTRACT

The structural integrity of the host red blood cell (RBC) is crucial for propagation of Plasmodium spp. during the disease-causing blood stage of malaria infection. To assess the stability of Plasmodium vivax-infected reticulocytes, we developed a flow cytometry-based assay to measure osmotic stability within characteristically heterogeneous reticulocyte and P. vivax-infected samples. We find that erythroid osmotic stability decreases during erythropoiesis and reticulocyte maturation. Of enucleated RBCs, young reticulocytes which are preferentially infected by P. vivax, are the most osmotically stable. P. vivax infection however decreases reticulocyte stability to levels close to those of RBC disorders that cause hemolytic anemia, and to a significantly greater degree than P. falciparum destabilizes normocytes. Finally, we find that P. vivax new permeability pathways contribute to the decreased osmotic stability of infected-reticulocytes. These results reveal a vulnerability of P. vivax-infected reticulocytes that could be manipulated to allow in vitro culture and develop novel therapeutics.


Subject(s)
Malaria, Vivax , Plasmodium vivax , Reticulocytes/metabolism , Reticulocytes/parasitology , Anemia, Hemolytic , Bone Marrow , Cell Differentiation , Erythrocytes , Hemolysis , Humans , Malaria
5.
J Infect Dis ; 223(10): 1817-1821, 2021 05 28.
Article in English | MEDLINE | ID: mdl-32941614

ABSTRACT

Plasmodium vivax has 2 invasion ligand/host receptor pathways (P. vivax Duffy-binding protein/Duffy antigen receptor for chemokines [DARC] and P. vivax reticulocyte binding protein 2b/transferrin receptor [TfR1]) that are promising targets for therapeutic intervention. We optimized invasion assays with isogenic cultured reticulocytes. Using a receptor blockade approach with multiple P. vivax isolates, we found that all strains utilized both DARC and TfR1, but with significant variation in receptor usage. This suggests that P. vivax, like Plasmodium falciparum, uses alternative invasion pathways, with implications for pathogenesis and vaccine development.


Subject(s)
Antigens, CD , Duffy Blood-Group System , Malaria, Vivax , Plasmodium vivax , Receptors, Cell Surface , Receptors, Transferrin , Cells, Cultured , Humans , Plasmodium vivax/pathogenicity , Reticulocytes/parasitology
6.
Article in English | MEDLINE | ID: mdl-33360105

ABSTRACT

Emerging antimalarial drug resistance may undermine current efforts to control and eliminate Plasmodium vivax, the most geographically widespread yet neglected human malaria parasite. Endemic countries are expected to assess regularly the therapeutic efficacy of antimalarial drugs in use in order to adjust their malaria treatment policies, but proper funding and trained human resources are often lacking to execute relatively complex and expensive clinical studies, ideally complemented by ex vivo assays of drug resistance. Here we review the challenges for assessing in vivo P. vivax responses to commonly used antimalarials, especially chloroquine and primaquine, in the presence of confounding factors such as variable drug absorption, metabolism and interaction, and the risk of new infections following successful radical cure. We introduce a simple modeling approach to quantify the relative contribution of relapses and new infections to recurring parasitemias in clinical studies of hypnozoitocides. Finally, we examine recent methodological advances that may render ex vivo assays more practical and widely used to confirm P. vivax drug resistance phenotypes in endemic settings and review current approaches to the development of robust genetic markers for monitoring chloroquine resistance in P. vivax populations.


Subject(s)
Antimalarials , Malaria, Vivax , Antimalarials/pharmacology , Antimalarials/therapeutic use , Chloroquine/pharmacology , Chloroquine/therapeutic use , Humans , Malaria, Vivax/drug therapy , Malaria, Vivax/epidemiology , Plasmodium vivax/genetics , Primaquine/pharmacology , Primaquine/therapeutic use
7.
BMC Bioinformatics ; 21(1): 300, 2020 Jul 11.
Article in English | MEDLINE | ID: mdl-32652926

ABSTRACT

BACKGROUND: A common yet still manual task in basic biology research, high-throughput drug screening and digital pathology is identifying the number, location, and type of individual cells in images. Object detection methods can be useful for identifying individual cells as well as their phenotype in one step. State-of-the-art deep learning for object detection is poised to improve the accuracy and efficiency of biological image analysis. RESULTS: We created Keras R-CNN to bring leading computational research to the everyday practice of bioimage analysts. Keras R-CNN implements deep learning object detection techniques using Keras and Tensorflow ( https://github.com/broadinstitute/keras-rcnn ). We demonstrate the command line tool's simplified Application Programming Interface on two important biological problems, nucleus detection and malaria stage classification, and show its potential for identifying and classifying a large number of cells. For malaria stage classification, we compare results with expert human annotators and find comparable performance. CONCLUSIONS: Keras R-CNN is a Python package that performs automated cell identification for both brightfield and fluorescence images and can process large image sets. Both the package and image datasets are freely available on GitHub and the Broad Bioimage Benchmark Collection.


Subject(s)
Deep Learning , Image Processing, Computer-Assisted/methods , Software , Cell Nucleus , Humans , Plasmodium vivax/growth & development
8.
PLoS Negl Trop Dis ; 14(3): e0008104, 2020 03.
Article in English | MEDLINE | ID: mdl-32119669

ABSTRACT

Approximately one-third of the global population is at risk of Plasmodium vivax infection, and an estimated 7.51 million cases were reported in 2017. Although, P. vivax research is currently limited by the lack of a robust continuous in vitro culture system for this parasite, recent work optimizing short-term ex vivo culture of P. vivax from cryopreserved isolates has facilitated quantitative assays on synchronous parasites. Pairing this improved culture system with low-input Smart-seq2 RNAseq library preparation, we sought to determine whether transcriptional profiling of P. vivax would provide insight into the differential survival of parasites in different culture media. To this end we probed the transcriptional signature of three different ex vivo P. vivax samples in four different culture media using only 1000 cells for each time point taken during the course of the intraerythrocytic development cycle (IDC). Using this strategy, we achieved similar quality transcriptional data to previously reported P. vivax transcriptomes. We found little effect with varying culture media on parasite transcriptional signatures, identified many novel gametocyte-specific genes from transcriptomes of FACS-isolated gametocytes, and determined invasion ligand expression in schizonts in biological isolates and across the IDC. In total, these data demonstrate the feasibility and utility of P. vivax RNAseq-based transcriptomic studies using minimal biomass input to maximize experimental capacity.


Subject(s)
Erythrocytes/parasitology , Gene Expression Profiling , Host-Pathogen Interactions , Malaria, Vivax/parasitology , Plasmodium vivax/growth & development , Adolescent , Child , Child, Preschool , Culture Media/chemistry , Female , Humans , Infant , Infant, Newborn , Male , Parasitology/methods , Plasmodium vivax/genetics , Sequence Analysis, RNA
9.
Am J Hematol ; 94(9): 963-974, 2019 09.
Article in English | MEDLINE | ID: mdl-31148215

ABSTRACT

Malaria pathogenesis is caused by the replication of Plasmodium parasites within the red blood cells (RBCs) of the vertebrate host. This selective pressure has favored the evolution of protective polymorphisms in erythrocyte proteins, a subset of which serve as cognate receptors for parasite invasion ligands. Recently, the generation of RBCs from immortalized hematopoietic stem cells (HSCs) has offered a more tractable system for genetic manipulation and long-term in vitro culture, enabling elucidation of the functional determinants of host susceptibility in vitro. Here we report the generation of an immortalized erythroid progenitor cell line (EJ cells) from as few as 100 000 peripheral blood mononuclear cells. It offers a robust method for the creation of customized model systems from small volumes of peripheral blood. The EJ cell differentiation mirrored erythropoiesis of primary HSCs, yielding orthochromatic erythroblasts and enucleated RBCs after eight days (ejRBCs). The ejRBCs supported invasion by both P. vivax and P. falciparum. To demonstrate the genetic tractability of this system, we used CRISPR/Cas9 to disrupt the Duffy Antigen/Receptor for Chemokines (DARC) gene, which encodes the canonical receptor of P. vivax in humans. Invasion of P. vivax into this DARC-knockout cell line was strongly inhibited providing direct genetic evidence that P. vivax requires DARC for RBC invasion. Further, genetic complementation of DARC restored P. vivax invasion. Taken together, the peripheral blood immortalization method presented here offers the capacity to generate biologically representative model systems for studies of blood-stage malaria invasion from the peripheral blood of donors harboring unique genetic backgrounds, or rare polymorphisms.


Subject(s)
Erythroid Precursor Cells , Malaria, Falciparum , Malaria, Vivax , Models, Biological , Peripheral Blood Stem Cells , Plasmodium falciparum/metabolism , Plasmodium vivax/metabolism , Cell Line, Transformed , Erythroid Precursor Cells/metabolism , Erythroid Precursor Cells/parasitology , Erythroid Precursor Cells/physiology , Humans , Malaria, Falciparum/metabolism , Malaria, Falciparum/pathology , Malaria, Vivax/metabolism , Malaria, Vivax/pathology , Peripheral Blood Stem Cells/metabolism , Peripheral Blood Stem Cells/parasitology , Peripheral Blood Stem Cells/pathology
10.
Curr Opin Microbiol ; 46: 109-115, 2018 12.
Article in English | MEDLINE | ID: mdl-30366310

ABSTRACT

Plasmodium vivax is uniquely restricted to invading reticulocytes, the youngest of red blood cells. Parasite invasion relies on the sequential deployment of multiple parasite invasion ligands. Correct targeting of the host reticulocyte is mediated by two families of invasion ligands: the reticulocyte binding proteins (RBPs) and erythrocyte binding proteins (EBPs). The Duffy receptor has long been established as a key determinant for P. vivax invasion. However, recently, the RBP protein PvRBP2b has been shown to bind to transferrin receptor, which is expressed on reticulocytes but lost on normocytes, implicating the ligand-receptor in the reticulocyte tropism of P. vivax. Furthermore there is increasing evidence for P. vivax growth and sexual development in reticulocyte-enriched tissues such as the bone marrow.


Subject(s)
Malaria, Vivax/parasitology , Plasmodium vivax/physiology , Reticulocytes/parasitology , Animals , Host-Parasite Interactions , Humans , Plasmodium vivax/genetics , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Tropism
11.
Science ; 359(6371): 48-55, 2018 01 05.
Article in English | MEDLINE | ID: mdl-29302006

ABSTRACT

Plasmodium vivax shows a strict host tropism for reticulocytes. We identified transferrin receptor 1 (TfR1) as the receptor for P. vivax reticulocyte-binding protein 2b (PvRBP2b). We determined the structure of the N-terminal domain of PvRBP2b involved in red blood cell binding, elucidating the molecular basis for TfR1 recognition. We validated TfR1 as the biological target of PvRBP2b engagement by means of TfR1 expression knockdown analysis. TfR1 mutant cells deficient in PvRBP2b binding were refractory to invasion of P. vivax but not to invasion of P. falciparum Using Brazilian and Thai clinical isolates, we show that PvRBP2b monoclonal antibodies that inhibit reticulocyte binding also block P. vivax entry into reticulocytes. These data show that TfR1-PvRBP2b invasion pathway is critical for the recognition of reticulocytes during P. vivax invasion.


Subject(s)
Antigens, CD/metabolism , Malaria, Vivax/metabolism , Malaria, Vivax/parasitology , Membrane Proteins/chemistry , Plasmodium vivax/pathogenicity , Protozoan Proteins/chemistry , Receptors, Transferrin/metabolism , Reticulocytes/parasitology , Antigens, CD/genetics , Crystallography, X-Ray , Gene Knockdown Techniques , Host-Parasite Interactions , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Proteins/ultrastructure , Plasmodium vivax/metabolism , Protein Domains , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Protozoan Proteins/ultrastructure , Receptors, Transferrin/genetics
12.
Article in English | MEDLINE | ID: mdl-29378713

ABSTRACT

Plasmodium vivax chloroquine resistance has been documented in nearly every region where this malaria-causing parasite is endemic. Unfortunately, P. vivax resistance surveillance and drug discovery are challenging due to the low parasitemias of patient isolates and poor parasite survival through ex vivo maturation that reduce the sensitivity and scalability of current P. vivax antimalarial assays. Using cryopreserved patient isolates from Brazil and fresh patient isolates from India, we established a robust enrichment method for P. vivax parasites. We next performed a medium screen for formulations that enhance ex vivo survival. Finally, we optimized an isotopic metabolic labeling assay for measuring P. vivax maturation and its sensitivity to antimalarials. A KCl Percoll density gradient enrichment method increased parasitemias from small-volume ex vivo isolates by an average of >40-fold. The use of Iscove's modified Dulbecco's medium for P. vivax ex vivo culture approximately doubled the parasite survival through maturation. Coupling these with [3H]hypoxanthine metabolic labeling permitted sensitive and robust measurements of parasite maturation, which was used to measure the sensitivities of Brazilian P. vivax isolates to chloroquine and several novel antimalarials. These techniques can be applied to rapidly and robustly assess the P. vivax isolate sensitivities to antimalarials for resistance surveillance and drug discovery.


Subject(s)
Antimalarials/pharmacology , Chloroquine/pharmacology , Parasitic Sensitivity Tests/methods , Plasmodium vivax/drug effects , Brazil , Humans , India
13.
Free Radic Biol Med ; 112: 318-326, 2017 11.
Article in English | MEDLINE | ID: mdl-28782644

ABSTRACT

Constitutive activation of the pro-survival transcription factor NF-κB has been associated with resistance to both chemotherapy and radiation therapy in many human cancers, including prostate cancer. Our lab and others have demonstrated that the natural product parthenolide can inhibit NF-κB activity and sensitize PC-3 prostate cancers cells to X-rays in vitro; however, parthenolide has poor bioavailability in vivo and therefore has little clinical utility in this regard. We show here that treatment of PC-3 and DU145 human prostate cancer cells with dimethylaminoparthenolide (DMAPT), a parthenolide derivative with increased bioavailability, inhibits constitutive and radiation-induced NF-κB binding activity and slows prostate cancer cell growth. We also show that DMAPT increases single and fractionated X-ray-induced killing of prostate cancer cells through inhibition of DNA double strand break repair and also that DMAPT-induced radiosensitization is, at least partially, dependent upon the alteration of intracellular thiol reduction-oxidation chemistry. Finally, we demonstrate that the treatment of PC-3 prostate tumor xenografts with oral DMAPT in addition to radiation therapy significantly decreases tumor growth and results in significantly smaller tumor volumes compared to xenografts treated with either DMAPT or radiation therapy alone, suggesting that DMAPT might have a potential clinical role as a radiosensitizing agent in the treatment of prostate cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Gene Expression Regulation, Neoplastic , NF-kappa B/antagonists & inhibitors , Prostatic Neoplasms/therapy , Radiation-Sensitizing Agents/pharmacology , Sesquiterpenes/pharmacology , Animals , BH3 Interacting Domain Death Agonist Protein/genetics , BH3 Interacting Domain Death Agonist Protein/metabolism , Cell Line, Tumor , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , DNA Breaks, Double-Stranded , DNA Repair/drug effects , DNA Repair/radiation effects , Humans , Male , Mice , Mice, Nude , NF-kappa B/genetics , NF-kappa B/metabolism , Prostate/drug effects , Prostate/metabolism , Prostate/pathology , Prostate/radiation effects , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Radiation Tolerance/drug effects , Signal Transduction , X-Rays , Xenograft Model Antitumor Assays , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism
14.
Article in English | MEDLINE | ID: mdl-34938593

ABSTRACT

Deep learning based models have had great success in object detection, but the state of the art models have not yet been widely applied to biological image data. We apply for the first time an object detection model previously used on natural images to identify cells and recognize their stages in brightfield microscopy images of malaria-infected blood. Many micro-organisms like malaria parasites are still studied by expert manual inspection and hand counting. This type of object detection task is challenging due to factors like variations in cell shape, density, and color, and uncertainty of some cell classes. In addition, annotated data useful for training is scarce, and the class distribution is inherently highly imbalanced due to the dominance of uninfected red blood cells. We use Faster Region-based Convolutional Neural Network (Faster R-CNN), one of the top performing object detection models in recent years, pre-trained on ImageNet but fine tuned with our data, and compare it to a baseline, which is based on a traditional approach consisting of cell segmentation, extraction of several single-cell features, and classification using random forests. To conduct our initial study, we collect and label a dataset of 1300 fields of view consisting of around 100,000 individual cells. We demonstrate that Faster R-CNN outperforms our baseline and put the results in context of human performance.

15.
Rev. bras. med. esporte ; 22(6): 496-500, nov.-dez. 2016. tab
Article in Portuguese | LILACS | ID: biblio-829961

ABSTRACT

RESUMO Introdução: Observa-se um pronunciado aumento da popularidade das corridas de rua; consequentemente, há mais adeptos dessa prática. Assim sendo, vários estudos vêm buscando diversas abordagens da modalidade, visando desvendar os mecanismos que a compõem. Objetivo: Verificar a incidência de lesões em praticantes de corrida de rua do município de Criciúma, SC, assim como outros fatores associados, como perfil dos praticantes, características do treinamento e existência de acompanhamento profissional. Métodos: Foi realizado um estudo descritivo transversal com 88 corredores (56 homens e 32 mulheres). Resultados: A média de idade foi 36 anos, sendo que a maioria dos participantes praticava corrida três vezes por semana (55,4%) e, do total da amostra, 43,2% já haviam tido alguma lesão, sendo o joelho (52,6%) o local mais acometido. Entre os que já tinham sofrido lesão, houve forte correlação entre quantidade de lesões e o tempo de prática da modalidade (r = 0,269) e os que percorriam maior distância média diária de treino (r = 0,226). No entanto, os dados demonstraram que o trabalho preventivo não foi eficaz na diminuição de incidência de lesão (r = -0,133). Conclusão: Há uma relação direta entre distância percorrida e lesão, bem como o tempo de prática. A orientação de profissionais não tem influência significativa na redução das lesões, ou seja, muitas lesões podem ser decorrentes do volume e da intensidade dos treinos prescritos ou executados de maneira equivocada, não respeitando o condicionamento físico atual e a individualidade biológica, na perspectiva de superar seus próprios limites de qualquer modo. Ressaltamos a importância de mais estudos que relacionem a progressão de treinamento, lesão e prevenção.


ABSTRACT Introduction: There has been a marked increase in the popularity of street running; consequently, more people are taking up this sport. Therefore, studies are seeking different approaches to this modality, aiming to unravel the mechanisms that compose it. Objective: To verify the incidence of injuries in street runners of Criciúma city, SC, as well as other related factors such as profile of practitioners, training characteristics, and the existence of professional monitoring. Methods: A cross-sectional descriptive study with 88 runners (56 men and 32 women) was conducted. Results: The mean age was 36 years, with most participants practicing running three times a week (55.4%) and in the total sample, 43.2% had an injury, with the knee (52.6%) being the most commonly affected. Among those who had suffered injury, there was a strong correlation between the number of injuries and the time spent practicing this sport (r=0.269) and those who trained in higher average daily distances (r=0.226). However, the data showed that preventive work was not effective in reducing the incidence of lesions (r=-0.133). Conclusion: There is a direct relationship between the distance run and injury, as well as the time spent practicing the sport. Professional guidance does not have a significant influence in reducing injuries, i.e., many injuries may be due to the volume and intensity of training that is incorrectly prescribed or executed, not respecting the current physical condition and the biological individuality, targeting only the perspective to overcome the athlete's own limitations at any cost. We point out the importance of more studies that associate the progression of training, injuries, and prevention.


RESUMEN Introducción: Hubo un marcado aumento en la popularidad de las carreras de calle; en consecuencia, hay más seguidores de esta práctica. De este modo, varios estudios han buscado diferentes enfoques de la modalidad con el objetivo de desvendar los mecanismos que lo componen. Objetivo: Verificar la incidencia de lesiones en practicantes de carrera de calle del municipio de Criciúma, SC, así como otros factores relacionados, tales como el perfil de los practicantes, las características del entrenamiento, y la existencia de un acompañamiento profesional. Métodos: Se realizó un estudio descriptivo transversal de 88 corredores (56 hombres y 32 mujeres). Resultados: La edad promedio fue de 36 años, con la mayoría de los participantes practicando carrera tres veces a la semana (55,4%) y de la muestra total, el 43,2% tenían una lesión, siendo la rodilla (52,6%) más comúnmente afectada. Entre los que habían sufrido lesiones, hubo una fuerte correlación entre el número de lesiones y el de tiempo de práctica (r = 0,269), y los que recorrían mayor distancia promedio diaria (r = 0,226). Sin embargo, los datos mostraron que el trabajo preventivo no fue efectivo en la reducción de la incidencia de las lesiones (r = -0,133). Conclusión: Existe una relación directa entre la distancia recorrida y lesiones, así como el tiempo de práctica. La orientación profesional no tiene influencia significativa en la reducción de las lesiones, es decir, muchas lesiones pueden deberse al volumen y la intensidad de entrenamiento que se prescribe o que no es correctamente realizado, sin respetar la condición física actual y la individualidad biológica con el fin de superar sus propios límites de todas las maneras. Enfatizamos la importancia de realizar más estudios que relacionan la progresión del entrenamiento, las lesiones y la prevención.

SELECTION OF CITATIONS
SEARCH DETAIL
...